Ventures

Sanifit is a drug development company that is developing treatments for calcification disorders where hydroxyapatite (HAP) crystals form and grow in blood vessels, leading to stiffer and narrower arteries.

Thesan Pharmaceuticals developed novel therapeutics for disorders of the skin.

Discovery of new pharmaceuticals for the treatment of cancer within the field of epigenetics.

Developed dermatological drugs, the lead being an H4 receptor antagonist tested in Atopic Dermatitis and Psoriasis patients.

Tiburio Therapeutics is a drug development company that develops novel small molecule treatments for potentially life-threatening rare neuroendocrine tumours and endocrine diseases such as non-functioning pituitary adenoma (NFPA).

Enliven Therapeutics is developing a novel, chronic, oral treatment for patients with sickle cell disease and other haemoglobinopathies.

VHsquared has developed a platform of oral biologics – Vorabodies™ – for inflammatory bowel disease.

Trevi Therapeutics develops Nalbuphine® ER for chronic pruritus (itch).

Acacia Pharma is a commercial stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy.

Nexstim offers navigated brain stimulation solutions which help diagnose and treat challenging brain diseases and disorders with confidence.